Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

There have been lots of disparaging arguments directed at CEO Ehrlich, including ones that harp on the company being suspect because merely a "one man band."

I suspect Leo has been working on the annual report, while also interacting with NIAID, NIH and the Military, getting ready for the conference last week, and perhaps taking calls of interest from Pharmas. The "very easy" recertification in Nevada shouldn't be hard to correct, once the very busy CEO gets to it (just ask Mrs. Ehrlich).

Demanding to know "at this moment" about the readiness of the annual report, who is in it, and the temporary lapse of good standing, won't make the information available any sooner, so we'll all have to wait a few days more. We'll also find out about any hypothetical "default standing" which actually doesn't seem to have affected shares trading in a "marketplace" that is not a real "exchange."

Let us know if an NT gets filed. It sometimes happens to small companies who are "one man bands" with lots on their plate. Unless the belief is that Leo is still poolside sipping a drink?

Funny thing is, all is forgiven if one or more deals get struck, or funding is obtained. Do you think that might happen in the next month or two?

Are there any questions about the number of viruses Brilacidin effectively inhibits in vitro?

Any idea if the military has been quietly testing the drug?

This post is in response to:

As of this moment has the Annual Report due on 8/31/21 been filed and will that be adequate to allow for the restoration of an Active status? Or willl the Company still be in Default based on the Annual Report due on 8/31/22 (and already late)?